ENTA short interest
Enanta Pharmaceuticals Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 2,552,994 |
|---|---|
| Change vs prior report | -47,205 (-1.8%) |
| Change over six months | +19.7% |
| Days to cover | 9.19 (sector: 3.78) |
| Average daily volume | 277,685 |
| Rank in Healthcare | #139 of 922 by days to cover |
ENTA short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 2,552,994 | -1.8% | 9.19 | 277,685 |
| 2026-09-15 | 2,600,199 | -0.6% | 10.72 | 242,451 |
| 2026-08-31 | 2,616,446 | -2.4% | 10.15 | 257,672 |
| 2026-08-14 | 2,679,755 | +3.6% | 14.74 | 181,762 |
| 2026-07-31 | 2,587,297 | +6.0% | 17.68 | 146,348 |
| 2026-07-15 | 2,441,185 | -5.5% | 12.77 | 191,239 |
| 2026-06-30 | 2,583,579 | +6.4% | 8.09 | 319,284 |
| 2026-06-15 | 2,427,371 | +6.7% | 12.80 | 189,612 |
| 2026-05-29 | 2,274,248 | +3.2% | 10.96 | 207,421 |
| 2026-05-15 | 2,202,731 | +2.2% | 9.37 | 235,034 |
| 2026-04-30 | 2,155,192 | +2.6% | 18.82 | 114,533 |
| 2026-04-15 | 2,101,431 | -1.5% | 17.29 | 121,515 |
| 2026-03-31 | 2,133,058 | -1.4% | 15.54 | 137,290 |
| 2026-03-13 | 2,163,844 | -1.1% | 11.24 | 192,550 |
| 2026-02-27 | 2,187,043 | -3.9% | 12.10 | 180,675 |
| 2026-02-13 | 2,275,475 | +0.7% | 11.63 | 195,576 |
| 2026-01-30 | 2,260,780 | +0.2% | 10.23 | 221,101 |
| 2026-01-15 | 2,255,154 | +8.2% | 8.47 | 266,368 |
| 2025-12-31 | 2,083,389 | -8.8% | 4.45 | 468,282 |
| 2025-12-15 | 2,284,705 | -7.9% | 7.72 | 296,022 |
| 2025-11-28 | 2,480,681 | -11.5% | 7.60 | 326,568 |
| 2025-11-14 | 2,803,161 | +2.5% | 9.41 | 297,869 |
| 2025-10-31 | 2,734,788 | -2.8% | 5.22 | 524,013 |
| 2025-10-15 | 2,814,736 | -16.0% | 3.37 | 835,768 |
| 2025-09-30 | 3,350,309 | +17.6% | 1.66 | 2,021,887 |
import finzdata as yf
yf.Ticker("ENTA").short_interest # every report since 2017
yf.Client().short_interest(["ENTA"], start="2018-01-01")Healthcare short interest · ENTA price history · Who owns ENTA · All short interest